Feature Channels: Vaccines

Filters close
Released: 26-Jul-2022 11:35 AM EDT
Public health researchers develop web-based guide to help family physicians address COVID-19 vaccine hesitancy
American Academy of Family Physicians (AAFP)

Public health researchers in Canada developed an interactive, web-based guide to help family physicians better address a wide range of patient concerns related to the COVID-19 vaccine.

20-Jul-2022 12:00 PM EDT
Novel Research Sheds Light on Antibody Responses to the SARS-CoV-2 Virus and Vaccines
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

Two studies presented today at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo reveal how SARS-CoV-2 antibody levels vary among recipients of COVID-19 vaccines and naturally infected individuals. These findings add to a growing body of knowledge that is essential for guiding public health initiatives, and that might one day enable clinicians to assess individuals’ immunity to SARS-CoV-2.

Released: 22-Jul-2022 2:30 PM EDT
Neutralization efficacy of antibodies against Omicron variants BA.1 and BA.2 declines quickly
Goethe University Frankfurt

The Omicron variant of the SARS-CoV-2 virus was first detected in South Africa in November 2021. The high level of infectiousness of the virus and its ability to quickly spawn additional variants has also been observed in Germany: Since January 2022 the Omicron variant BA.1 has dominated here, followed in subsequent months by the variant BA.2.

Released: 22-Jul-2022 12:15 PM EDT
In brief: COVID-19 vaccine does not negatively affect placental health
Weill Cornell Medicine

Vaccination against COVID-19 had no impact on the health of placentas in pregnant women, according to new research by pathologists at Weill Cornell Medicine and NewYork-Presbyterian.

Newswise: Your Body Remembers Common Cold Coronaviruses From Childhood
How Can You Get the Same Immunity to Covid-19?
Released: 21-Jul-2022 5:25 PM EDT
Your Body Remembers Common Cold Coronaviruses From Childhood How Can You Get the Same Immunity to Covid-19?
La Jolla Institute for Immunology

For a glimpse into the future of SARS-CoV-2 immunity, scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system builds its defenses against common cold coronaviruses (CCCs).

Newswise: A Novel COVID-19 Vaccine Using Modified Bacterial DNA
20-Jul-2022 2:05 PM EDT
A Novel COVID-19 Vaccine Using Modified Bacterial DNA
UC San Diego Health

UC San Diego researchers describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.

Released: 21-Jul-2022 1:10 PM EDT
COVID vaccines averted infection in 10% of patient-facing healthcare staff during second wave
BMJ

The rapid covid-19 vaccine rollout from December 2020 averted infection in a large proportion of NHS hospital workers in England during the second wave of the pandemic, suggests research published by The BMJ today.

Newswise: Texas Biomed working to accelerate COVID-19 drug development
Released: 21-Jul-2022 10:55 AM EDT
Texas Biomed working to accelerate COVID-19 drug development
Texas Biomedical Research Institute

Researchers at Texas Biomed have received approval to work with a weakened, non-harmful version of SARS-CoV-2 in biosafety level 2 (BSL-2) laboratories, which makes it safer, faster and easier to study the virus, its mutations, and to identify new treatments for COVID-19.

Released: 21-Jul-2022 8:00 AM EDT
How Vaccine-Related Fears Affect the Flu Shot Experience
Ohio State University

A novel long-term study of how vaccine-related fears influence flu shot outcomes has found that these fears not only reduce vaccination, but also fuel symptoms of dizziness and lightheadedness at the time of the injection.

20-Jul-2022 8:50 AM EDT
Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, 6 months after second doses, finds study of over 7 million adults
University of Bristol

Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the University of Bristol-led study published in The BMJ today [July 20], found protection in older adults aged over 65 years, and in clinically vulnerable adults.

Released: 20-Jul-2022 4:35 PM EDT
New fast test discriminates between cellular immunity to SARS-CoV-2 after vaccination or infection
Medical University of Vienna (MedUni Wien)

A MedUni Vienna research team has developed a new blood test that indicates a person's status of cellular immunity to SARS-CoV-2 within just 48 hours.

Newswise: Putting the brakes on
17-Jul-2022 9:00 PM EDT
Putting the brakes on "budding" viruses
La Jolla Institute for Immunology

Paramyxoviruses have the potential to trigger a devastating pandemic. This family of viruses includes measles, Nipah virus, mumps, Newcastle disease and canine distemper. An international team of collaborators has published the first-ever look at a key stage in the life cycles of measles and Nipah viruses. It reveals how future therapies might stop these viruses in their tracks.

Released: 19-Jul-2022 3:05 PM EDT
Vaccine-induced immune response to omicron wanes substantially over time
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial data.

Released: 19-Jul-2022 3:05 PM EDT
Shorter Wait Between COVID-19 and Elective Surgery Possible
Kaiser Permanente

Kaiser Permanente researchers have good news for patients, surgeons, anesthesiologists, and hospital administrators who have had to put off elective surgery because of a positive COVID-19 test.

12-Jul-2022 12:05 PM EDT
COVID-19 patients more likely to develop cardiovascular diseases and diabetes soon after infection
PLOS

Disease risk returns to baseline after 23 weeks for diabetes, and 7 weeks for cardiovascular diseases.

Newswise: New Genomic Research Shows Why Testing Malaria Vaccines in the Clinic is as Rigorous as Natural Exposure in the Field
Released: 19-Jul-2022 11:55 AM EDT
New Genomic Research Shows Why Testing Malaria Vaccines in the Clinic is as Rigorous as Natural Exposure in the Field
University of Maryland School of Medicine

Scientists at the University of Maryland School of Medicine’s (UMSOM) Institute for Genome Sciences (IGS) and the UMSOM Center for Vaccine Development and Global Health (CVD), and their collaborators report a new way to test vaccines that may be as rigorous and stringent as exposure to field strains of malaria.

Newswise: Six-Country African Study Shows COVID-19 Can Be Dangerous in Pregnancy
Released: 18-Jul-2022 4:30 PM EDT
Six-Country African Study Shows COVID-19 Can Be Dangerous in Pregnancy
Institute of Human Virology at the University of Maryland School of Medicine

A new study involving hospitalized women in 6 African countries from the University of Maryland School of Medicine’s Institute of Human Virology showed that pregnant women with SARS-CoV-2 had 2X the risk of being admitted to the ICU and 4X the risk of dying than pregnant women who didn't have COVID-19.

Released: 15-Jul-2022 4:30 PM EDT
In survey, COVID-19 vaccine recipients report changes in menstrual bleeding
University of Illinois Urbana-Champaign

A new analysis of reports from more than 35,000 people offers the most comprehensive assessment so far of menstrual changes experienced by pre- and post-menopausal individuals in the first two weeks after receiving the COVID-19 vaccine.

Newswise: Texas Biomed tapped for national ‘Dream Team’ developing antivirals against COVID-19 and other threats
Released: 15-Jul-2022 3:50 PM EDT
Texas Biomed tapped for national ‘Dream Team’ developing antivirals against COVID-19 and other threats
Texas Biomedical Research Institute

Texas Biomedical Research Institute Professor Luis Martinez-Sobrido, PhD, an expert in virology, vaccines and antiviral research, has been recruited to collaborate with three of the nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern announced by NIH this spring.

Newswise: Microparticles could be used to deliver “self-boosting” vaccines
Released: 15-Jul-2022 10:35 AM EDT
Microparticles could be used to deliver “self-boosting” vaccines
Massachusetts Institute of Technology (MIT)

Most vaccines, from measles to Covid-19, require a series of multiple shots before the recipient is considered fully vaccinated.

Newswise: The Medical Minute: Monkeypox cases on the rise
Released: 14-Jul-2022 7:05 AM EDT
The Medical Minute: Monkeypox cases on the rise
Penn State Health

Like the coronavirus pandemic, misinformation about monkeypox is mounting along with the number of cases. A Penn State Health infectious disease doctor cuts through the white noise in this week’s Medical Minute.

Released: 13-Jul-2022 4:05 PM EDT
Microparticles could be used to deliver “self-boosting” vaccines
Massachusetts Institute of Technology (MIT)

Most vaccines, from measles to Covid-19, require a series of multiple shots before the recipient is considered fully vaccinated.

8-Jul-2022 10:05 AM EDT
Patients with Lupus Benefit from COVID-19 Vaccine Booster
NYU Langone Health

People with systemic lupus erythematosus, or SLE, who received a “booster” dose of SARS-CoV-2 vaccine after full vaccination are roughly half as likely to have a subsequent “breakthrough” COVID-19 infection, a new study shows.

Released: 12-Jul-2022 11:05 AM EDT
Vaccine Attitudes Detected in Tweets by AI Model
University of Warwick

An intelligent AI model developed by the University of Warwick can detect social media users’ stances and concerns towards vaccinations.

Released: 11-Jul-2022 1:55 PM EDT
Adults with Blood Cancers Respond to Booster, Not Initial Dose of COVID-19 Vaccine
Wiley

Most patients in the study mounted immune responses after a booster dose, and no patient with antibody responses died from COVID-19.

Newswise: Familiarity Breeds Exempt: Why Staph Vaccines Don’t Work in Humans
5-Jul-2022 4:05 PM EDT
Familiarity Breeds Exempt: Why Staph Vaccines Don’t Work in Humans
UC San Diego Health

UC San Diego researchers say they may have found the reason why multiple human clinical trials of staphylococcus vaccines have failed: the bacteria knows us too well.

Newswise: Collaboration Advances DNA-delivered Antibodies to Prevent COVID-19
7-Jul-2022 9:20 AM EDT
Collaboration Advances DNA-delivered Antibodies to Prevent COVID-19
Wistar Institute

Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) funded program, a novel COVID-19 antibody delivery approach has advanced to clinical trials.

Released: 6-Jul-2022 3:00 PM EDT
Chatbot-Delivered COVID-19 Vaccine Communication Message Preferences of Young Adults and Public Health Workers in Urban American Communities: Qualitative Study
Journal of Medical Internet Research

Background: Automated conversational agents, or chatbots, have a role in reinforcing evidence-based guidance delivered through other media and offer an accessible, individually tailored channel for public engagement. In early-to-mid ...

Released: 6-Jul-2022 2:30 PM EDT
Impact of COVID-19 Vaccine Misinformation on Social Media Virality: Content Analysis of Message Themes and Writing Strategies
Journal of Medical Internet Research

Background: Vaccines serve an integral role in containing pandemics, yet vaccine hesitancy is prevalent globally. One key reason for this hesitancy is the pervasiveness of misinformation on social media. Although considerable researc...

Newswise: Study Explores Unusual Interaction Between Viruses, Live Vaccines
Released: 6-Jul-2022 1:05 PM EDT
Study Explores Unusual Interaction Between Viruses, Live Vaccines
University of Illinois Urbana-Champaign

A study of a herpes virus that infects chickens offers new insights into potentially problematic interactions between vaccines made from live viruses and the viruses they are meant to thwart.

Released: 6-Jul-2022 2:05 AM EDT
Nanoparticle vaccine protects against a spectrum of COVID-19-causing variants and related viruses
California Institute of Technology

A new type of vaccine provides protection against a variety of SARS-like betacoronaviruses, including SARS-CoV-2 variants, in mice and monkeys, according to a study led by researchers in the laboratory of Caltech's Pamela Bjorkman, the David Baltimore Professor of Biology and Bioengineering.

Released: 5-Jul-2022 3:05 PM EDT
Inhalable COVID-19 Vaccine Shows Promise in Rodent Model
North Carolina State University

Researchers have created an inhalable COVID-19 vaccine that is shelf stable at room temperature for up to three months, targets the lungs specifically and effectively, and allows for self-administration via an inhaler.

Newswise: Nanoparticle Vaccine Protects Against a Spectrum of COVID-19-Causing Variants and Related Viruses
Released: 5-Jul-2022 2:45 PM EDT
Nanoparticle Vaccine Protects Against a Spectrum of COVID-19-Causing Variants and Related Viruses
California Institute of Technology

A new type of vaccine provides protection against a variety of SARS-like betacoronaviruses, including SARS-CoV-2 variants, in mice and monkeys, according to a study led by researchers in the laboratory of Caltech's Pamela Bjorkman, the David Baltimore Professor of Biology and Bioengineering.

Released: 5-Jul-2022 1:25 PM EDT
Study Reveals Why Highly Infectious Cholera Variant Mysteriously Died Out
University of Cambridge

A new study reveals why a highly infectious variant of the cholera bug, which caused large disease outbreaks in the early 1990s, did not cause the eighth cholera pandemic as feared – but instead unexpectedly disappeared.

Released: 5-Jul-2022 10:05 AM EDT
Age May Rival Politics in COVID-19 Vaccine Debate
University of Georgia

New research from the University of Georgia suggests age and risk perception may have as much of an effect on COVID-19 vaccine acceptance as party affiliation.

   
Released: 5-Jul-2022 9:45 AM EDT
South Asian Communities in GTA disproportionately hit by COVID-19
McMaster University

A COVID CommUNITY – South Asian study, published in the Canadian Medical Association Journal (CMAJ) Open has found that South Asian communities living in the Greater Toronto Area (GTA) suffered disproportionately from COVID-19 in the first year of the pandemic.

Released: 1-Jul-2022 12:15 PM EDT
COVID-19 Vaccine Protects People of All Body Weights From Hospitalization and Death, Study of 9 Million Adults in England Suggests
Lancet

COVID-19 vaccines greatly reduced the number of cases of severe COVID-19 disease for everyone regardless of their body size, according to a new study published in The Lancet Diabetes & Endocrinology. Vaccine effectiveness was similar for those with a higher BMI and of a healthy weight, but slightly lower in the underweight group, who were also the least likely to have been vaccinated.

Newswise: New Universal Flu Vaccine Offers Broad Protection Against Influenza A Virus Infections, Researchers Find
Released: 1-Jul-2022 11:50 AM EDT
New Universal Flu Vaccine Offers Broad Protection Against Influenza A Virus Infections, Researchers Find
Georgia State University

A new universal flu vaccine constructed with key parts of the influenza virus offers broad cross protection against different strains and subtypes of influenza A viruses in young and aged populations, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

Released: 1-Jul-2022 10:55 AM EDT
Plug-and-play test for keeping track of immunity to Sars-CoV-2 variants
University of Toronto

The experts agree — the pandemic is not over. Infections are ticking up again, fueled by the new variants our immune systems are ill prepared for.

Released: 1-Jul-2022 10:25 AM EDT
New Antibody Detection Method for Coronavirus That Does Not Require a Blood Sample
Institute of Industrial Science, The University of Tokyo

Despite significant and stunning advances in vaccine technology, the COVID-19 global pandemic is not over.

Newswise: New Technique for Detecting Typhoid Infections Faster, More Accurate Than Conventional Testing, According to Study
Released: 29-Jun-2022 3:15 PM EDT
New Technique for Detecting Typhoid Infections Faster, More Accurate Than Conventional Testing, According to Study
UC Davis Health (Defunct)

A new technique for detecting typhoid infections is faster and more accurate than conventional testing, according to a new study. The new approach can significantly help disease monitoring and vaccination planning. An estimated 11 to 20 million people get sick from typhoid every year.

Released: 28-Jun-2022 2:05 PM EDT
Interrupting the Treatment of Vulnerable People on Immune-Suppressing Medicines, Doubles Their Antibody Response to COVID-19 Booster Vaccination
University of Nottingham

A major clinical trial, led by experts at the University of Nottingham working in partnership with several Universities and NHS hospitals, has found that by interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled.

Released: 28-Jun-2022 11:05 AM EDT
CoVPN Trial: Novavax’s Traditional COVID-19 Vaccine Correlates to Strong Antibody Response, Protection Against SARS-CoV-2
Covid-19 Prevention Network (CoVPN)

A new analysis of the Novavax PREVENT-19 clinical trial concluded that this recombinant protein vaccine produced an antibody response comparable to mRNA vaccines and, if authorized, could help bolster global vaccine supplies. This is the first study to directly support antibody correlates of protection for a recombinant protein COVID-19 vaccine.

23-Jun-2022 12:15 PM EDT
Immune Molecules From a Llama Could Provide Protection Against a Vast Array of SARS-like Viruses Including COVID-19, Researchers Say
Mount Sinai Health System

Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses.

Released: 27-Jun-2022 3:05 PM EDT
Kids and the COVID-19 Vaccine: Eleven Key Questions Answered
Children's Hospital Los Angeles

With the vaccine for children ages 6 months and older approved, the experts at Children’s Hospital Los Angeles provide guidance for families. The Centers for Disease Control and Prevention (CDC) recommends that everyone approved to receive a COVID-19 vaccine get one—including children ages 6 months and older.

Released: 27-Jun-2022 1:45 PM EDT
The latest expert commentary on SCOTUS decisions, including the overturn of Roe v. Wade
Newswise

The latest expert commentary and research on SCOTUS decisions, including the overturn of Roe v. Wade

       
Newswise: UTHealth Houston study: Flu vaccination linked to 40% reduced risk of Alzheimer’s disease
Released: 24-Jun-2022 12:30 PM EDT
UTHealth Houston study: Flu vaccination linked to 40% reduced risk of Alzheimer’s disease
University of Texas Health Science Center at Houston

People who received at least one influenza vaccine were 40% less likely than their non-vaccinated peers to develop Alzheimer’s disease over the course of four years, according to a new study from UTHealth Houston.

Released: 24-Jun-2022 11:05 AM EDT
COVID-19 Vaccination in Pregnancy Helps Protect Infants from Needing Hospital Care for COVID-19
Ann and Robert H. Lurie Children's Hospital of Chicago

In a new study sponsored by the Centers for Disease Control and Prevention and published in the New England Journal of Medicine, researchers provide additional evidence that COVID-19 vaccination during pregnancy helps protect babies younger than 6 months from being hospitalized due to COVID-19. The risk of COVID-19 hospitalization among babies was reduced by about 80 percent during the Delta wave (July 1–December 18, 2021) and 40 percent during the Omicron wave (December 19–March 8, 2022).



close
2.45772